Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products in the self-pay aesthetic market. We believe these attributes represent a compelling value proposition:
Aesthetic neurotoxins are the largest segment of the fast-growing $12 billion global aesthetics market. With its high regulatory barriers to entry, the economically resilient aesthetic neurotoxin market is poised for continued growth.
Jeuveau® was designed to compete clinically with the market leader. Results from our TRANSPARENCY global clinical program of more than 2,100 patients, including a head-to-head Phase III study comparing Jeuveau® to the market leader, provide physicians with confidence in recommending Jeuveau® to their patients.
Evolus offers an enhanced level of physician-customer interaction. Evolus specifically targets the self-pay aesthetic-only market. This offers us the ability to create meaningful competitive advantages, including pricing and marketing flexibility, that our competitors who also compete in reimbursed markets face significant challenges to achieve.
Millennials are the future of aesthetics. A growing and highly under-penetrated demographic, the health and wellness-conscious millennial consumer is proactive in adopting aesthetic treatments. Evolus‘ consumer loyalty program, aided by our strong digital capabilities, helps keep these consumers connected to the Jeuveau® brand.